Carbon dioxide (CO2) is essential throughout the professionally managed cannabis value chain, with major applications in growing and processing. In some cases, it is also used for trimming and freeze-drying. New pharmaceutical registrations and the loosening of recreational cannabis regulations will be major drivers of growth in carbon dioxide utilisation for cannabis applications.
After the election of Joe Biden as the New President in the US, there is the possibility that the marijuana legalisation debate in the US may regain momentum and federal policy may come closer to more liberal rules that exist in some states. At present, 35 states allow medical use of cannabis extracts and recreational use is permitted in 15 states.
The so-called ‘opioid crisis’ in the UnS will also motivate further investigation into the potential of cannabinoid painkillers. They are believed to have the potential to substitute opioid pharmaceuticals, which are derived from regulated growing of opium poppies but have highly addictive and often deadly side-effects. Clinical investigations are also underway into other therapies for child epilepsy and Alzheimer’s in the elderly.
... to continue reading you must be subscribed
